Evolution of CD8⁺ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer

Engineered T cell receptor T (TCR-T) cell therapy has facilitated the generation of increasingly reliable tumor antigen-specific adaptable cellular products for the treatment of human cancer. TCR-T cell therapies were initially focused on targeting shared tumor-associated peptide targets, including...

詳細記述

書誌詳細

主要な著者:	Yimo Sun, Fenge Li, Heather Sonnemann, Kyle R. Jackson, Amjad H. Talukder, Arjun S. Katailiha, Gregory Lizee
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2021-09-01
シリーズ:	Cells
主題:	T-cell receptor (TCR) engineered TCR-T cell therapy tumor antigen clinical trials cancer treatment
オンライン･アクセス:	https://www.mdpi.com/2073-4409/10/9/2379
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!